Certara announces the release of Simcyp™ PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types Press Release Certara announces the release of Simcyp™ PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types Simcyp Simulator has been utilized to inform more than 300 label claims for 90+ novel…CertaraMarch 7, 2023
GlobalSubmit™ eCTD Platform Fact Sheet GlobalSubmit™ eCTD Platform GlobalSubmit enables teams to simplify the eCTD submission process to successfully publish, validate, and review…CertaraMarch 3, 2023
Drug Development Considerations for Live Biotherapeutic Products Blog Drug Development Considerations for Live Biotherapeutic Products A new class of complex biologics has emerged in recent years. These are classified in…CertaraMarch 3, 2023
Advancing data discovery in the life sciences through artificial intelligence Press Coverage Advancing data discovery in the life sciences through artificial intelligence Vyasa has developed deep-learning artificial intelligence solutions for organizations looking to solve the complex data…CertaraMarch 2, 2023
Certara Announces Transition Plan For Chief Financial Officer Press Release Certara Announces Transition Plan For Chief Financial Officer PRINCETON, N.J. – March 1, 2023 – Certara, Inc. (Nasdaq: CERT), announced today that John…CertaraMarch 1, 2023
Learn how to create CDISC domains in minutes with PK Submit On-Demand Webinar Learn how to create CDISC domains in minutes with PK Submit Creating CDISC domains as part of the pharmacokinetic (PK) deliverable for regulatory submissions can be…CertaraMarch 1, 2023
Understanding Europe’s New Clinical Trial Regulations (EU-CTR) White Paper Understanding Europe’s New Clinical Trial Regulations (EU-CTR) While the new EU-CTR will help to streamline clinical trials, which will benefit both patients…CertaraFebruary 27, 2023
Common Clinical Trial Disclosure Challenges & Potential Solutions Blog Common Clinical Trial Disclosure Challenges & Potential Solutions Pharmaceutical companies are being required to be more transparent through the timely disclosure of more…CertaraFebruary 24, 2023